Zhejiang Shapuaisi Pharmaceutical Co.,Ltd. (603168.SS)
CNY 6.51
(1.4%)
CNY 6.51
(1.4%)
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2023 | -179.97 Million CNY | 62.92% |
| 2022 | -485.37 Million CNY | -381.0% |
| 2021 | -100.9 Million CNY | -2.2% |
| 2020 | -98.73 Million CNY | 55.82% |
| 2019 | -223.48 Million CNY | -53.96% |
| 2018 | -145.16 Million CNY | 66.89% |
| 2017 | -438.41 Million CNY | 9.58% |
| 2016 | -484.86 Million CNY | -312.15% |
| 2015 | -117.64 Million CNY | 35.66% |
| 2014 | -182.84 Million CNY | -346.03% |
| 2013 | 74.31 Million CNY | -12.71% |
| 2012 | 85.14 Million CNY | 65.2% |
| 2011 | 51.53 Million CNY | 246.84% |
| 2010 | 14.85 Million CNY | -31.73% |
| 2009 | 21.76 Million CNY | -40.2% |
| 2008 | 36.39 Million CNY | 0.0% |
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2024 Q3 | -81 Million CNY | -82.41% |
| 2024 Q1 | 5.62 Million CNY | 103.13% |
| 2024 Q2 | 99.22 Million CNY | 1662.78% |
| 2023 Q1 | -399.74 Million CNY | 17.64% |
| 2023 Q4 | -179.97 Million CNY | 26.44% |
| 2023 FY | -179.97 Million CNY | 62.92% |
| 2023 Q3 | -244.67 Million CNY | 18.27% |
| 2023 Q2 | -299.38 Million CNY | 25.11% |
| 2022 Q4 | -485.37 Million CNY | -226.84% |
| 2022 Q3 | -148.5 Million CNY | 8.65% |
| 2022 Q2 | -162.57 Million CNY | 26.97% |
| 2022 Q1 | -222.61 Million CNY | -120.61% |
| 2022 FY | -485.37 Million CNY | -381.0% |
| 2021 Q4 | -100.9 Million CNY | 32.46% |
| 2021 Q1 | -219.4 Million CNY | -122.21% |
| 2021 FY | -100.9 Million CNY | -2.2% |
| 2021 Q2 | -191.58 Million CNY | 12.68% |
| 2021 Q3 | -149.41 Million CNY | 22.01% |
| 2020 Q3 | -382.44 Million CNY | 45.78% |
| 2020 Q1 | -262.09 Million CNY | -17.28% |
| 2020 FY | -98.73 Million CNY | 55.82% |
| 2020 Q4 | -98.73 Million CNY | 74.18% |
| 2020 Q2 | -705.39 Million CNY | -169.13% |
| 2019 Q2 | -191.18 Million CNY | 6.04% |
| 2019 Q4 | -223.48 Million CNY | -17.7% |
| 2019 FY | -223.48 Million CNY | -53.96% |
| 2019 Q1 | -203.46 Million CNY | -40.16% |
| 2019 Q3 | -189.87 Million CNY | 0.68% |
| 2018 Q2 | -108.14 Million CNY | 54.65% |
| 2018 Q4 | -145.16 Million CNY | -4.42% |
| 2018 Q3 | -139.01 Million CNY | -28.55% |
| 2018 FY | -145.16 Million CNY | 66.89% |
| 2018 Q1 | -238.47 Million CNY | 45.6% |
| 2017 Q3 | -376.74 Million CNY | -55.69% |
| 2017 FY | -438.41 Million CNY | 9.58% |
| 2017 Q4 | -438.41 Million CNY | -16.37% |
| 2017 Q2 | -241.98 Million CNY | 51.36% |
| 2017 Q1 | -497.52 Million CNY | -2.61% |
| 2016 Q1 | -83.7 Million CNY | 28.85% |
| 2016 Q2 | -94.1 Million CNY | -12.43% |
| 2016 Q4 | -484.86 Million CNY | -242.58% |
| 2016 Q3 | -141.53 Million CNY | -50.4% |
| 2016 FY | -484.86 Million CNY | -312.15% |
| 2015 Q2 | -116.31 Million CNY | 25.5% |
| 2015 Q1 | -156.13 Million CNY | 14.61% |
| 2015 FY | -117.64 Million CNY | 35.66% |
| 2015 Q4 | -117.64 Million CNY | 32.74% |
| 2015 Q3 | -174.9 Million CNY | -50.37% |
| 2014 Q2 | -274.25 Million CNY | -543.53% |
| 2014 Q1 | 61.83 Million CNY | -16.8% |
| 2014 FY | -182.84 Million CNY | -346.03% |
| 2014 Q4 | -182.84 Million CNY | -29.96% |
| 2014 Q3 | -140.69 Million CNY | 48.7% |
| 2013 Q4 | 74.31 Million CNY | 0.0% |
| 2013 FY | 74.31 Million CNY | -12.71% |
| 2013 Q1 | 91.75 Million CNY | 0.0% |
| 2012 FY | 85.14 Million CNY | 65.2% |
| 2011 Q3 | 65.06 Million CNY | 0.0% |
| 2011 FY | 51.53 Million CNY | 246.84% |
| 2011 Q4 | 51.53 Million CNY | -20.79% |
| 2010 FY | 14.85 Million CNY | -31.73% |
| 2009 FY | 21.76 Million CNY | -40.2% |
| 2008 FY | 36.39 Million CNY | 0.0% |